Omar Barakat, MD
General Surgery · Houston, TXNPI 1649260969
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $123,035 of the $145,226 with a category attached, or 84.7%. Ipsen Biopharmaceuticals, Inc accounts for 99.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $56,016 and has fallen 99.8% since, to $105 in 2025. Among general surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $1171.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$144K
- Johnson & Johnson$328
- Tersera Therapeutics LLC$240
- Boston Scientific$107
- Angiodynamics, Inc.$105
- Wound Management Technologies, Inc$77
- plus $47 from 2 others
What the payments were for
- Speaking & faculty fees$123,03585%
- Travel & lodging$18,08212%
- Food & beverage$4,1103%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 108 | $144,323 |
| Johnson & Johnson | 3 | $328 |
| Tersera Therapeutics LLC | 3 | $240 |
| Boston Scientific | 2 | $107 |
| Angiodynamics, Inc. | 2 | $105 |
| Wound Management Technologies, Inc | 3 | $77 |
| TELA Bio, Inc. | 2 | $32 |
| Axonics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONIVYDE$104,192
- SOMATULINE DEPOT$41,299
- Echelon Flex$149
- Enseal$149
- Xermelo$125
- NEUWAVE Flex Microwave Ablation System$106
How this compares
$145,226 in reported general payments places this provider in the 95th percentile of 61 general surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ursodiol | 17 | $2,511 |
| Tramadol Hcl | 45 | $115 |
| Metoclopramide Hcl | 13 | $31 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Houston
- Younan NowzaradanHouston$13K
- Priya PrakashHouston$6K
- Matthew PiotrowskiHouston$804
- Claire OzakiHouston$338
- Helen JohnsonHouston$0
- Adam SmithFort Worth$62K
- Aaron BranskyPlano$32K
- Michael DarnellFt Worth$18K
- Jay StaufferFredericksburg$17K
- Dean KocayAustin$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.